Xtandi

Fierce Pharma

Astellas CEO resists 'rescue BD' as Xtandi patent cliff nears

With Xtandi set to lose U.S. patent protection next year, Astellas’ CEO fielded questions this week about his company’s BD strategy ahead of the loss.

Angus Liu Jan 15, 2026 10:42am

Pfizer shares prostate cancer data after leak, inks Alloy deal

Feb 11, 2025 1:07pm

failure crash no fail rocket cancelled end

Essa drops lead cancer drug after falling short against Xtandi

Nov 1, 2024 7:33am

Arvinas eyes a busy 2021 as protein degraders gather steam

Dec 14, 2020 10:32am

Astellas to halt work at R&D subsidiary amid restructuring plan

May 23, 2018 2:16pm

Micrograph showing the most common prostate cancer

Researchers create test to predict response to Xtandi, Zytiga

May 5, 2017 9:24am